Unknown

Dataset Information

0

Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20.


ABSTRACT: Drug-resistance threatens effective treatment of HIV/AIDS. Clinical inhibitors, including darunavir (1), are ineffective for highly resistant protease mutant PR20, however, antiviral compound 2 derived from 1 with fused tricyclic group at P2, extended amino-benzothiazole P2' ligand and two fluorine atoms on P1 shows 16-fold better inhibition of PR20 enzyme activity. Crystal structures of PR20 and wild-type PR complexes reveal how the extra groups of 2 counteract the expanded ligand-binding pocket, dynamic flaps, and faster dimer dissociation of PR20.

SUBMITTER: Kneller DW 

PROVIDER: S-EPMC7251940 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20.

Kneller Daniel W DW   Agniswamy Johnson J   Ghosh Arun K AK   Weber Irene T IT  

Biochemical and biophysical research communications 20190829 1


Drug-resistance threatens effective treatment of HIV/AIDS. Clinical inhibitors, including darunavir (1), are ineffective for highly resistant protease mutant PR20, however, antiviral compound 2 derived from 1 with fused tricyclic group at P2, extended amino-benzothiazole P2' ligand and two fluorine atoms on P1 shows 16-fold better inhibition of PR20 enzyme activity. Crystal structures of PR20 and wild-type PR complexes reveal how the extra groups of 2 counteract the expanded ligand-binding pocke  ...[more]

Similar Datasets

| S-EPMC3355519 | biostudies-literature
| S-EPMC6545544 | biostudies-literature
| S-EPMC5613016 | biostudies-literature
| S-EPMC6601333 | biostudies-literature
| S-EPMC4695280 | biostudies-literature
| S-EPMC2751596 | biostudies-literature
| S-EPMC2253353 | biostudies-literature
| S-EPMC5389583 | biostudies-literature
| S-EPMC3015180 | biostudies-other
| S-EPMC5850901 | biostudies-literature